The pharmaceutical industry’s reaction to President Trump’s executive order on drug prices? It could have been worse.Shares ...

Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

Donald Trump has vowed to cut the US’s globally high drug prices by as much as 80 per cent with an executive order that seeks to force other countries to pay more for their medicines.

Trump signs executive order setting 30-day deadline for drugmakers to lower prescription drug costs. Drugmakers aren't happy.

In an executive order Monday morning, Trump announced plans to reduce drug prices by 30 to 80%.

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...

Citi downgraded both AbbVie (NYSE:ABBV) and Merck (NSE:PROR) to Neutral in separate notes Wednesday, citing long-term growth concerns and late-stage pipeline limitations as headwinds for the ...